Kroger announces definitive agreement for sale of its specialty pharmacy business

Specialty pharmacy serves patients with chronic illnesses who require complex care cincinnati , march 18, 2024 /prnewswire/ -- the kroger co. (nyse: kr) announced that it has entered into a definitive agreement for the sale of its specialty pharmacy business to carelonrx, a subsidiary of elevance health. "kroger specialty pharmacy has been part of our company since 2012, and we want to thank our management team and associates for their enduring commitment to their patients," said colleen lindholz, president of kroger health.
KR Ratings Summary
KR Quant Ranking